Esthesioneuroblastoma staging: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
Simrat Sarai (talk | contribs)
CMEUser, nocaptcha
5,683 edits
Mmir (talk | contribs)
CMEAdmin, CMEUser, Bureaucrats, bureaucrats, nocaptcha, smwadministrator, Administrators, Widget editors
14,850 edits
Mahshid
 
(6 intermediate revisions by 2 users not shown)
Line 3: Line 3:
{{CMG}}{{AE}}{{Simrat}}
{{CMG}}{{AE}}{{Simrat}}
==Overview==
==Overview==
According to a staging system by Kadish, there are four stages of esthesioneuroblastoma based upon the extent of the primary tumor and lymph node or distant metastases. In 1992, Dulguerov and Calceterra proposed a classification based on the tumor, node, metastasis (TNM) system, predicted on CT and MRI findings that can be identified before treatment.<ref name="pmid1260676">{{cite journal| author=Kadish S, Goodman M, Wang CC| title=Olfactory neuroblastoma. A clinical analysis of 17 cases. | journal=Cancer | year= 1976 | volume= 37 | issue= 3 | pages= 1571-6 | pmid=1260676 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1260676  }} </ref><ref name="pmid8492845">{{cite journal| author=Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM| title=Esthesioneuroblastoma: prognosis and management. | journal=Neurosurgery | year= 1993 | volume= 32 | issue= 5 | pages= 706-14; discussion 714-5 | pmid=8492845 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8492845  }} </ref><ref name="pmid1495347">{{cite journal| author=Dulguerov P, Calcaterra T| title=Esthesioneuroblastoma: the UCLA experience 1970-1990. | journal=Laryngoscope | year= 1992 | volume= 102 | issue= 8 | pages= 843-9 | pmid=1495347 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1495347  }} </ref>
According to a staging system by Kadish, there are four stages of esthesioneuroblastoma based upon the extent of the primary tumor and [[lymph node]] or distant [[metastases]]. In 1992, Dulguerov and Calceterra proposed a classification based on the [[tumor]], node, [[metastasis]] (TNM) system, predicted on [[CT]] and [[MRI]] findings that can be identified before treatment.<ref name="pmid1260676">{{cite journal| author=Kadish S, Goodman M, Wang CC| title=Olfactory neuroblastoma. A clinical analysis of 17 cases. | journal=Cancer | year= 1976 | volume= 37 | issue= 3 | pages= 1571-6 | pmid=1260676 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1260676  }} </ref><ref name="pmid8492845">{{cite journal| author=Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM| title=Esthesioneuroblastoma: prognosis and management. | journal=Neurosurgery | year= 1993 | volume= 32 | issue= 5 | pages= 706-14; discussion 714-5 | pmid=8492845 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8492845  }} </ref><ref name="pmid1495347">{{cite journal| author=Dulguerov P, Calcaterra T| title=Esthesioneuroblastoma: the UCLA experience 1970-1990. | journal=Laryngoscope | year= 1992 | volume= 102 | issue= 8 | pages= 843-9 | pmid=1495347 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1495347  }} </ref>


==Staging==
==Staging==
*The most widely used approach is the Kadish clinical staging system. Kadish et al were the first to propose a staging classification for esthesioneuroblastoma (ENB). ENBs were divided into three categories: groups A, B, and C.
*The most widely used approach is the Kadish clinical staging system. Kadish et al were the first to propose a staging classification for esthesioneuroblastoma (ENB). Esthesioneuroblastomas were divided into three categories: groups A, B, and C.
*Group A is limited to tumors of the nasal fossa  
*Group A is limited to tumors of the nasal fossa.
*Group B, extension is to the paranasal sinuses
*Group B, extension is to the [[paranasal sinuses]].
*Group C is defined as extension beyond the paranasal sinuses and nasal cavity.<ref name="pmid1260676">{{cite journal| author=Kadish S, Goodman M, Wang CC| title=Olfactory neuroblastoma. A clinical analysis of 17 cases. | journal=Cancer | year= 1976 | volume= 37 | issue= 3 | pages= 1571-6 | pmid=1260676 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1260676  }} </ref>
*Group C is defined as extension beyond the paranasal sinuses and nasal cavity.<ref name="pmid1260676">{{cite journal| author=Kadish S, Goodman M, Wang CC| title=Olfactory neuroblastoma. A clinical analysis of 17 cases. | journal=Cancer | year= 1976 | volume= 37 | issue= 3 | pages= 1571-6 | pmid=1260676 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1260676  }} </ref>
*In 1993, Morita et al published a revised Kadish system that redefined stage C (consisting of local disease spreading beyond the paranasal sinuses) and included a stage D (distant metastasis).<ref name="pmid8492845">{{cite journal| author=Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM| title=Esthesioneuroblastoma: prognosis and management. | journal=Neurosurgery | year= 1993 | volume= 32 | issue= 5 | pages= 706-14; discussion 714-5 | pmid=8492845 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8492845  }} </ref>
*In 1993, Morita et al published a revised Kadish system that redefined stage C (consisting of local disease spreading beyond the paranasal sinuses) and included a stage D (distant metastasis).<ref name="pmid8492845">{{cite journal| author=Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM| title=Esthesioneuroblastoma: prognosis and management. | journal=Neurosurgery | year= 1993 | volume= 32 | issue= 5 | pages= 706-14; discussion 714-5 | pmid=8492845 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8492845  }} </ref>
*In 1992, Dulguerov and Calceterra proposed a classification based on the tumor, node, metastasis (TNM) system, which is predicated on CT and MRI findings that can be identified before treatment.<ref name="pmid1495347">{{cite journal| author=Dulguerov P, Calcaterra T| title=Esthesioneuroblastoma: the UCLA experience 1970-1990. | journal=Laryngoscope | year= 1992 | volume= 102 | issue= 8 | pages= 843-9 | pmid=1495347 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1495347  }} </ref>
*In 1992, Dulguerov and Calceterra proposed a classification based on the tumor, node, metastasis (TNM) system, which is predicted on CT and MRI findings that can be identified before treatment.<ref name="pmid1495347">{{cite journal| author=Dulguerov P, Calcaterra T| title=Esthesioneuroblastoma: the UCLA experience 1970-1990. | journal=Laryngoscope | year= 1992 | volume= 102 | issue= 8 | pages= 843-9 | pmid=1495347 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1495347  }} </ref>
 
===Kadish staging of Esthesioneuroblastoma===
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center
|valign=top|
|valign=top|
|+
|+
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Group}}
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Stage}}
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Features}}
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Features}}
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
:Group A
:Stage A
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Tumor is limited to the nasal cavity
*Tumor is limited to the nasal cavity
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
:Group B
:Stage B
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Tumor is limited to the nasal cavity and paranasal sinuses
*Tumor is limited to the nasal cavity and paranasal sinuses
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
:Group C
:Stage C
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Extension beyond the nasal cavity and paranasal sinuses  
*Extension beyond the nasal cavity and paranasal sinuses  
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
:Group D
:Stage D
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Regional lymph node or distant metastasis
*Regional lymph node or distant metastasis
Line 102: Line 102:
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{Central nervous system tumors}}


[[Category:Disease]]
[[Category:Disease]]
Line 109: Line 107:
[[Category:neurology]]
[[Category:neurology]]
[[Category:Rhinology]]
[[Category:Rhinology]]
[[Category:Needs content]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Neurology]]
[[Category:Neurosurgery]]

Latest revision as of 23:19, 26 November 2017

Esthesioneuroblastoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Esthesioneuroblastoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esthesioneuroblastoma staging On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esthesioneuroblastoma staging

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esthesioneuroblastoma staging

CDC on Esthesioneuroblastoma staging

Esthesioneuroblastoma staging in the news

Blogs on Esthesioneuroblastoma staging

Directions to Hospitals Treating Esthesioneuroblastoma

Risk calculators and risk factors for Esthesioneuroblastoma staging

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

According to a staging system by Kadish, there are four stages of esthesioneuroblastoma based upon the extent of the primary tumor and lymph node or distant metastases. In 1992, Dulguerov and Calceterra proposed a classification based on the tumor, node, metastasis (TNM) system, predicted on CT and MRI findings that can be identified before treatment.[1][2][3]

Staging

  • The most widely used approach is the Kadish clinical staging system. Kadish et al were the first to propose a staging classification for esthesioneuroblastoma (ENB). Esthesioneuroblastomas were divided into three categories: groups A, B, and C.
  • Group A is limited to tumors of the nasal fossa.
  • Group B, extension is to the paranasal sinuses.
  • Group C is defined as extension beyond the paranasal sinuses and nasal cavity.[1]
  • In 1993, Morita et al published a revised Kadish system that redefined stage C (consisting of local disease spreading beyond the paranasal sinuses) and included a stage D (distant metastasis).[2]
  • In 1992, Dulguerov and Calceterra proposed a classification based on the tumor, node, metastasis (TNM) system, which is predicted on CT and MRI findings that can be identified before treatment.[3]

Kadish staging of Esthesioneuroblastoma
Stage Features
Stage A
  • Tumor is limited to the nasal cavity
Stage B
  • Tumor is limited to the nasal cavity and paranasal sinuses
Stage C
  • Extension beyond the nasal cavity and paranasal sinuses
Stage D
  • Regional lymph node or distant metastasis

T Categories of esthesioneuroblastoma
T Classification Thickness
T1
 Tumor involvong the nasal cavity and/or paranasal sinuses (excluding sphenoid), sparing the most superior ethmoid cells
T2
 Tumor involving the nasal cavity and/or paranasal sinuses (including the sphenoid), with extention to or erosion of the cribiform plate
T3
 Tumor extending into the orbit or protruding into the anterior cranial fossa, without dural invasion
T4
 Tumor involving the brain

N Categories of Esthesioneuroblastoma
N Lymph Node Features
N0
 No cervical lymph node metastasis
N1
 Any form of cervical lymph node metastases

M Categories of Esthesioneuroblastoma
N Lymph Node Features
M0
 No metastasis
M1
 Distant Metastases

References

  1. ↑ 1.0 1.1 Kadish S, Goodman M, Wang CC (1976). "Olfactory neuroblastoma. A clinical analysis of 17 cases". Cancer. 37 (3): 1571–6. PMID 1260676.
  2. ↑ 2.0 2.1 Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM (1993). "Esthesioneuroblastoma: prognosis and management". Neurosurgery. 32 (5): 706–14, discussion 714-5. PMID 8492845.
  3. ↑ 3.0 3.1 Dulguerov P, Calcaterra T (1992). "Esthesioneuroblastoma: the UCLA experience 1970-1990". Laryngoscope. 102 (8): 843–9. PMID 1495347.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Esthesioneuroblastoma_staging&oldid=1393548"